Skip to main content
TargetHIV
Tools for HRSA's Ryan White HIV/AIDS Program

User menu anonymous

  • Sign in
  • Sign up

Main menu

  • Home
  • News
    • News Feed
    • Blog Roll
    • Stay Informed: RW Email Lists
  • Events
    • TA Calendar
    • National Ryan White Conferences
    • Webinar Archives
  • Library
    • Best Practices Compilation
    • HIV Care Innovations
    • Clinical Quality Management
    • Data & Reporting
    • Ending the HIV Epidemic Initiative
    • Fiscal Management
    • Health Coverage
    • HIV Care Continuum
    • Key Populations
    • Medical & Support Services
    • People with HIV & Community
    • Planning
    • Program Management
    • RW HIV/AIDS Program Parts
    • Service Models
    • Glossary
    • Conference Presentations
    • Recursos disponibles en español
  • Community
    • Community Top Picks
    • Community Forums
    • Program Locator
  • Help
    • Technical Assistance Directory
    • TA Provider Support Ticket
    • ​About Us
    • Privacy Policy

Breadcrumb

  1. Home »
  2. IHIP Home »
  3. Buprenorphine »
  4. Curriculum

Integration of Buprenorphine into HIV Primary Care Settings: Curriculum

August 2012
Author(s): IHIPHRSA HIV/AIDS Bureau (HAB)

Table of Contents

  • Introduction
  • Module 1: Do We Have a Problem? Examining Opioid Use and HIV
  • Module 2: Key Terms and Definitions
  • Module 3: What are Opioids? What is MAT?
  • Module 4: Which Medications Are Used and How Do They Work?
  • Module 5: Key Findings From the SPNS Buprenorphine Initiative
  • Module 6: Prescribing Buprenorphine: How to Get Started
  • Module 7: Buprenorphine: Know the Facts
  • Module 8: Role Playing
  • Module 9: Patient Education
  • Module 10: Online Resources

Download Complete Curriculum (PDF)

Download Curriculum Slides (PPT)

Next >
Integrating HIV Innovative Practices -- Access Training Materials

TA - IHIP Main Menu

  • IHIP Home
    • Buprenorphine
      • Curriculum
        • Introduction
        • 1. Do We Have a Problem? Examining Opioid Use and HIV
        • 2. Key Terms & Definitions
        • 3. What are Opioids? What is MAT?
        • 4. Which Medications Are Used and How Do They Work?
        • 5. Key Findings from the SPNS Buprenorphine Initiative
        • 6. Prescribing Buprenorphine: How to Get Started
        • 7. Buprenorphine: Know the Facts
        • 8. Role Playing
        • 9. Patient Education
        • 10. Online Resources
      • Training Manual
      • Webinar: Clinical Aspects
      • Webinar: Training & Implementation
      • FAQ and Peer Discussion
    • Continuing Education Credits
    • Correctional Health Linkage Programs
    • Engaging Hard to Reach Populations
    • Integrating Hep C Treatment into HIV Care
    • Oral Health Care
    • Women of Color: Enhancing Access
    • Subscribe

Footer

  • Home
  • News
    • News Feed
    • Blog Roll
    • Stay Informed: RW Email Lists
  • Events
    • TA Calendar
    • National Ryan White Conferences
    • Webinar Archives
  • Library
    • Best Practices Compilation
    • HIV Care Innovations
    • Clinical Quality Management
    • Data & Reporting
    • Ending the HIV Epidemic Initiative
    • Fiscal Management
    • Health Coverage
    • HIV Care Continuum
    • Key Populations
    • Medical & Support Services
    • People with HIV & Community
    • Planning
    • Program Management
    • RW HIV/AIDS Program Parts
    • Service Models
    • Glossary
    • Conference Presentations
    • Recursos disponibles en español
  • Community
    • Community Top Picks
    • Community Forums
    • Program Locator
  • Help
    • Technical Assistance Directory
    • TA Provider Support Ticket
    • ​About Us
    • Privacy Policy

Social media links

TargetHIV

  • Visit us on Facebook (link is external)
  • Visit us on Twitter (link is external)
  • Visit us on YouTube (link is external)
HRSA - Ryan White & Global HIV/AIDS Program

Copyright © 2022. TargetHIV is funded by HHS, HRSA, HIV/AIDS Bureau under cooperative agreement #U69HA37645 with the University of California, San Francisco. Its contents are solely the responsibility of the authors. They do not necessarily represent the official views of the HIV/AIDS Bureau.